Cornely, O. A., & Heußel, C. P. (2014). A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial). Blood, 124(21), .
Chicago-Zitierstil (17. Ausg.)Cornely, Oliver Andreas, und Claus Peter Heußel. "A Double-blind,multicentre, Randomised, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome (R)) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard Trial)." Blood 124, no. 21 (2014).
MLA-Zitierstil (9. Ausg.)Cornely, Oliver Andreas, und Claus Peter Heußel. "A Double-blind,multicentre, Randomised, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome (R)) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard Trial)." Blood, vol. 124, no. 21, 2014.